In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative Melinda HollingsheadMichael AlleyEdward A. Sausville Original Article 25 March 2005 Pages: 115 - 125
Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models Victoria SmithEdward A. SausvilleAngelika M. Burger Original Article 20 April 2005 Pages: 126 - 137
A phase I study of doxifluridine combined with weekly paclitaxel for metastatic gastric cancer Toshikazu MoriwakiIchinosuke HyodoAkira Kurita Original Article 13 April 2005 Pages: 138 - 144
Preclinical pharmacokinetics and oral bioavailability of BMS-310705, a novel epothilone B analog Amrita V. KamathMing ChangPunit H. Marathe Original Article 14 April 2005 Pages: 145 - 153
Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours Lyly H. LêMalcolm J. MooreLesley Seymour Original Article 05 April 2005 Pages: 154 - 160
Single nucleotide polymorphisms modify the transporter activity of ABCG2 Kuniaki MorisakiRobert W. RobeySusan E. Bates Original Article 19 April 2005 Pages: 161 - 172
Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin Chantal BarthomeufJérôme GrassiRichard Béliveau Original Article 12 April 2005 Pages: 173 - 181
Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies James A. PoseyHui WangWilliam C. Zamboni Original Article 19 April 2005 Pages: 182 - 188
Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment J. Todd BulmerNatalie J. ZacalAndrew J. Rainbow Original Article 20 April 2005 Pages: 189 - 198
A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer Susan GoodinKamakshi V. RaoRobert S. DiPaola Original Article 19 April 2005 Pages: 199 - 204
Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5′-deoxy-5-fluorouridine (5′-DFUR) Hiromichi EbiYasushi SigeokaHironobu Minami Original Article 21 April 2005 Pages: 205 - 211
HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin Shu-zhen ChenMin JiangYong-su Zhen Original Article 06 April 2005 Pages: 212 - 220
Cytoprotective effects of amifostine and cysteamine on cultured normal and tumor cells treated with paclitaxel in terms of mitotic index and 3H-thymidine labeling index Gül Özcan Arican Original Article 19 April 2005 Pages: 221 - 229
